Omeprazole Activase Pharmaceuticals

Omeprazole, the active ingredient in Omeprazole Activase Pharmaceuticals, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children. GNH USA supplies Omeprazole Activase Pharmaceuticals as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole Activase Pharmaceuticals belongs to the proton pump inhibitor class and is indicated for conditions involving excess gastric acid secretion. - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease (duodenal and gastric ulcers): supports ulcer healing and reduces recurrence. - Helicobacter pylori eradication regimens: used as adjunct‑adjunct as part of triple‑therapy . - Zollinger‑Ellison syndrome: controls hyper‑secretion of acid by inhibiting the gastric parietal cell H‑​ . - NSA‑ -